548 results on '"Grayson, Peter C."'
Search Results
52. Reply
53. Ruxolitinib is more effective than other JAK inhibitors to treat VEXAS syndrome: a retrospective multicenter study
54. Genomic ascertainment for UBA1 variants and VEXAS syndrome: a population-based study
55. Brief Report: Drugs Implicated in Systemic Autoimmunity Modulate Neutrophil Extracellular Trap Formation
56. 18F‐Fluorodeoxyglucose–Positron Emission Tomography As an Imaging Biomarker in a Prospective, Longitudinal Cohort of Patients With Large Vessel Vasculitis
57. Reply.
58. Longitudinal Characterization of Vascular Inflammation and Disease Activity in Takayasu Arteritis and Giant Cell Arteritis: A Single‐Center Prospective Study.
59. 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for eosinophilic granulomatosis with polyangiitis
60. Response to eLetter: ‘Infections in giant cell arteritis and therapeutic implications’ by Moiseev et al
61. Association of 18F‐Fluorodeoxyglucose–Positron Emission Tomography Activity With Angiographic Progression of Disease in Large Vessel Vasculitis.
62. Risk of relapse of ANCA-associated vasculitis among patients homozygous for the proteinase 3 gene Val119Ile polymorphism.
63. Response to: Correspondence on ‘2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for granulomatosis with polyangiitis’ by Joanna C Robson et al and ‘2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for microscopic polyangiitis’ by Ravi Suppiah et al
64. 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Kawasaki Disease
65. VEXAS Syndrome: A Case Series From a Single‐Center Cohort of Italian Patients With Vasculitis
66. 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Eosinophilic Granulomatosis with Polyangiitis
67. 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for microscopic polyangiitis
68. 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for granulomatosis with polyangiitis
69. A prospective observational cohort study and systematic review of 40 patients with mouth and genital ulcers with inflamed cartilage (MAGIC) syndrome
70. Case 2-2022: A 70-Year-Old Man with a Recurrent Left Pleural Effusion
71. Use of 18F-fluorodeoxyglucose positron emission tomography to standardize clinical trial recruitment in Takayasu’s arteritis
72. Large-vessel vasculitis
73. Longitudinal Characterization of Vascular Inflammation and Disease Activity in Takayasu Arteritis and Giant Cell Arteritis: A Single‐CenterProspective Study
74. Somatic mutations in rheumatological diseases: VEXAS syndrome and beyond
75. Clinical Efficacy of JAK Inhibitors in Patients with Vexas Syndrome: A Multicenter Retrospective Study
76. Reply: On Semiquantitative Methods for Assessing Vascular 18F-FDG PET Activity in Large-Vessel Vasculitis
77. VEXAS syndrome: An inflammatory and hematologic disease
78. Diagnosis of Giant Cell Arteritis in an Asymptomatic Patient
79. 2022 American College of Rheumatology/EULAR Classification Criteria for Giant Cell Arteritis.
80. 2022 American College of Rheumatology/EULAR Classification Criteria for Takayasu Arteritis.
81. Discordance in patient and physician global assessment in relapsing polychondritis
82. Somatic Mutations in UBA1 Define a Distinct Subset of Relapsing Polychondritis Patients With VEXAS
83. Dynamic Changes in the Nasal Microbiome Associated With Disease Activity in Patients With Granulomatosis With Polyangiitis
84. 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Giant Cell Arteritis and Takayasu Arteritis
85. 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis
86. 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Polyarteritis Nodosa
87. Value of commonly measured laboratory tests as biomarkers of disease activity and predictors of relapse in eosinophilic granulomatosis with polyangiitis
88. Brief Report: Defining the Nasal Transcriptome in Granulomatosis With Polyangiitis (Wegenerʼs)
89. Neutrophil-Related Gene Expression and Low-Density Granulocytes Associated With Disease Activity and Response to Treatment in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis
90. Somatic mutations in rheumatological diseases: VEXAS syndrome and beyond.
91. Comparing Semiquantitative and Qualitative Methods of Vascular 18F-FDG PET Activity Measurement in Large-Vessel Vasculitis
92. VEXAS Syndrome
93. ACR/EULAR-endorsed study to develop Diagnostic and Classification Criteria for Vasculitis (DCVAS)
94. Eosinophils in vasculitis: characteristics and roles in pathogenesis
95. Discordance in patient and physician global assessment in relapsing polychondritis.
96. Use of 18F-fluorodeoxyglucose positron emission tomography to monitor tocilizumab effect on vascular inflammation in giant cell arteritis
97. Identification of susceptibility loci for Takayasu arteritis through a large multi-ancestral genome-wide association study
98. Ultrasound Assessment of Subcutaneous Compressibility: A Potential Adjunctive Diagnostic Tool in Eosinophilic Fasciitis
99. Behçet's Disease
100. Cocaine (Levamisole) Induced Vasculitis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.